Posted By - Investment Banker
A pure play branded generic marketing pharma company headquartered in Delhi with a pan India sales team of 300 medical reps with strong presence in north & east India selling brands across multiple therapeutic segments including Orthopedics with an expected turnover of Rs. 48 crores is looking for a strategic exit.
INR 65 - 70 Cr
Motives For Sellout
|2017 (in Cr)||2018 (in Cr)||2019 (in Cr)||2020 (in Cr)|
|Sales||N.D||INR 42 Cr||INR 48 Cr||N.D|